中遠海控(01919.HK)斥近55億人幣入股中糧福臨門逾5.8%
中遠海控(01919.HK)公布,認購中糧福臨門配售的近1.8億股,方式為公司對中糧福臨門出資近55億元人民幣(約63.8億港元)。
完成後,集團將持有中糧福臨門約5.81%股份,而後者不會成為公司附屬。中糧福臨門現有中糧股東持股約69.83%。
中糧福臨門主要從事食品加工及品牌銷售業務和全球農糧供應鏈業務;食品加工及品牌銷售業務經營品類主要包括米麵食品、食用油、啤酒原料加工、飼料原料等。
公司認為,以是次股權投融資合作為紐帶,雙方將進一步探索業務合作交集,實現全面深度融合與高品質發展,包括更好促進供應鏈全要素的深度對接、探討加強境內外碼頭投資及營運,以及推動數碼經濟和糧食、物流實體經濟深度融合。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.